{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:19Z","timestamp":1787236459331,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T00:00:00Z","timestamp":1757030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to develop predictive models based on preoperative clinicopathological and imaging features to accurately assess the individual risk of contralateral occult thyroid carcinoma (OTC) and determine the number of central lymph node metastasis (CLNM) in patients with unilateral papillary thyroid carcinoma, thereby providing actionable guidance for surgical planning.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Seven widely-used machine learning algorithms were employed to develop predictive models. Hyperparameter tuning was performed via cross-validation in combination with grid search. The models were subsequently trained and evaluated by using the optimal hyperparameter combinations. To facilitate comparative analysis, ROC curves, calibration curves were generated and DCA was performed. The optimal model was then selected on the basis of this comprehensive evaluation. Furthermore, a clinical prediction model was constructed utilizing the significant predictors identified.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The logistic regression model was identified to be the optimal predictive model. For the clinical prediction model of OTC, the following independent variables were incorporated: body mass index, and ultrasonographic findings, including capsular disruption, number of malignant nodules within a unilateral lobe, sum of the longest diameter (SLD) of tumors, and the presence of isthmic malignant nodule(s). This model yielded an area under the ROC curve (AUC) of 0.74 and 0.70 in the training and validation cohorts, respectively. For the clinical prediction model of \u22655 CLNM, the incorporated independent variables included: age, sex, chronic lymphocytic thyroiditis, and ultrasonographic features covering malignant nodules located near the isthmus, SLD, capsular disruption, and calcification. This model produced an AUC of 0.75 and 0.71 in the training and validation cohorts, respectively. Decision curve analysis indicated that clinical interventions guided by the two models could provide net benefit within threshold probability ranges of 10% to 90% and 10% to 70% for patients with PTC. And the calibration curves demonstrated a good agreement between model predictions and actual observations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study developed and validated clinical prediction models to estimate the risk of contralateral OTC and the presence of \u22655 CLNM in patients with unilateral PTC. These models were designed to prevent overtreatment in low-risk patients while providing evidence-based guidance for decision-making about treatment choice in high-risk patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2025.1623075","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:14:15Z","timestamp":1757045655000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Construction of predictive models for contralateral occult thyroid carcinoma and central lymph node metastasis in unilateral papillary thyroid carcinoma using machine learning"],"prefix":"10.3389","volume":"15","author":[{"given":"Yaqi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds230","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Pacini","year":"2012","journal-title":"Ann Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: A Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2019-00085","article-title":"Contemporary debates in adult papillary thyroid cancer management","volume":"40","author":"McLeod","year":"2019","journal-title":"Endocrine Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2017.01.020","article-title":"Evaluation of the presence of Epstein-Barr virus (EBV) in Iranian patients with thyroid papillary carcinoma","volume":"213","author":"Homayouni","year":"2017","journal-title":"Pathol Res Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28641","article-title":"Thyroid autoimmune diseases and thyroid tumors: Would EBV infection be the link","volume":"234","author":"de Almeida","year":"2019","journal-title":"J Cell Physiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinimag.2018.05.003","article-title":"Ultrasound requested by general practitioners or for symptoms unrelated to the thyroid gland may explain higher prevalence of thyroid nodules in females","volume":"50","author":"Germano","year":"2018","journal-title":"Clin Imaging"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: A review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2014.02.011","article-title":"Surgery for thyroid cancer","volume":"43","author":"Callender","year":"2014","journal-title":"Endocrinol Metab Clinics North America"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00343-7","article-title":"Trends in thyroid cancer incidence and overdiagnosis in the USA","volume":"13","author":"Dal Maso","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Cancer Network"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.03.031","article-title":"Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma","volume":"167","author":"Harries","year":"2020","journal-title":"Surgery"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24513","article-title":"Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement","volume":"38","author":"Scharpf","year":"2016","journal-title":"Head Neck"},{"key":"B15","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1089\/thy.2014.0098","article-title":"Management of recurrent\/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance","volume":"25","author":"Tufano","year":"2015","journal-title":"Thyroid"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.937738","article-title":"A review of the role of ultrasound radiomics and its application and limitations in the investigation of thyroid disease","volume":"28","author":"Lu","year":"2022","journal-title":"Med Sci Monitor"},{"key":"B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ejrad.2019.01.006","article-title":"Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: Diagnosis of central and lateral compartment nodal metastases","volume":"112","author":"Zhao","year":"2019","journal-title":"Eur J Radiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12113282","article-title":"Thyroid lobectomy for low to intermediate risk differentiated thyroid cancer","volume":"12","author":"Hartl","year":"2020","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0495","article-title":"Frequency of high-risk characteristics requiring total thyroidectomy for 1-4\u2009cm well-differentiated thyroid cancer","volume":"26","author":"Kluijfhout","year":"2016","journal-title":"Thyroid"},{"key":"B20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4097\/kja.21209","article-title":"Receiver operating characteristic curve: overview and practical use for clinicians","volume":"75","author":"Nahm","year":"2022","journal-title":"Korean J Anesthesiol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3343\/alm.2023.43.1.5","article-title":"Calibration practices in clinical mass spectrometry: review and recommendations","volume":"43","author":"Cheng","year":"2023","journal-title":"Ann Lab Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.spinee.2021.02.024","article-title":"Decision curve analysis to evaluate the clinical benefit of prediction models","volume":"21","author":"Vickers","year":"2021","journal-title":"Spine J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","article-title":"From local explanations to global understanding with explainable AI for trees","volume":"2","author":"Lundberg","year":"2020","journal-title":"Nat Mach Intell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jncc.2024.01.006","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Han","year":"2024","journal-title":"Zhonghua Zhong Liu Za Zhi Chin J Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"7594615","DOI":"10.1155\/2016\/7594615","article-title":"Safety and effectiveness of total thyroidectomy and its comparison with subtotal thyroidectomy and other thyroid surgeries: A systematic review","volume":"2016","author":"Padur","year":"2016","journal-title":"J Thyroid Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1330524","article-title":"Hypoparathyroidism following total thyroidectomy: high rates at a low-volume, non-parathyroid institution","volume":"15","author":"Abood","year":"2024","journal-title":"Front Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12957-017-1130-7","article-title":"Total thyroidectomy may be more reasonable as initial surgery in unilateral multifocal papillary thyroid microcarcinoma: a single-center experience","volume":"15","author":"Xue","year":"2017","journal-title":"World J Surg Oncol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoto.2022.0621","article-title":"Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: A systematic review and meta-analysis","volume":"148","author":"Hsiao","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0906-6","article-title":"Occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma","volume":"17","author":"Koo","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2012.06.019","article-title":"Papillary thyroid microcarcinoma with fatal outcome: evidence of tumor progression in lymph node metastases: report of 3 cases, with morphological and molecular analysis","volume":"44","author":"Piana","year":"2013","journal-title":"Hum Pathol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O","article-title":"Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods","volume":"71","author":"Martinez-Tello","year":"1993","journal-title":"Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"109103","DOI":"10.1016\/j.ejrad.2020.109103","article-title":"Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis","volume":"129","author":"Xing","year":"2020","journal-title":"Eur J Radiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"100156","DOI":"10.1016\/j.eehl.2025.100156","article-title":"Reinterpretation of a new ChatGPT-empowered, easy-to-use machine learning paradigm: An aide-memoire","volume":"4","author":"Sengul","year":"2025","journal-title":"Eco Environ Health"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20210763","article-title":"Blurred lines for management of thyroid nodules in the era of atypia of undetermined significance\/follicular lesion of undetermined significance: novel subdivisions of categories IIIA and IIIB in a possible forthcoming The Bethesda System for Reporting Thyroid Cytopathology, 3rd edition; amending versus unnecessary","volume":"67","author":"Sengul","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.20231511","article-title":"Evangely, the subcategorization has been announced in the 2023 Bethesda system for reporting thyroid cytopathology: let bygones be bygones in thyroidology","volume":"70","author":"Sengul","year":"2024","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1590\/1806-9282.67.02.20200828","article-title":"Focusing on thyroid nodules in suspense: 10\u201315 mm with repeat cytology, Category III, the Bethesda System for Reporting Thyroid Cytopathology, TBSRTC","volume":"67","author":"Sengul","year":"2021","journal-title":"Rev Assoc Med Bras (1992)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.14366\/usg.23113","article-title":"Subdivision of intermediate suspicion, the 2021 K-TIRADS, and category III, indeterminate cytology, the 2017 TBSRTC, 2nd edition, in thyroidology: let bygones be bygones","volume":"42","author":"Sengul","year":"2023","journal-title":"Ultrasonography"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1623075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T04:14:15Z","timestamp":1757045655000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1623075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":37,"alternative-id":["10.3389\/fonc.2025.1623075"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1623075","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]},"article-number":"1623075"}}